ATRA
Atara Biotherapeutics Inc
9.50$
+2.7%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 16.4 | 8.3 | 7.0 | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 4.7 | 3.6 | 3.9 | 4.5 | 75.7 | 38.9 | 11.1 | 5.5 | 5.4 | 5.2 | 24.5 | 35.1 | 6.4 | 2.8 | 0.8 | 0.6 | 1.1 | 0.3 | 0.5 | 1.3 | 1.9 | 2.9 | 27.9 | |
| 2.3 | 1.6 | 2.6 | 1.9 | 2.5 | 3.1 | 3.5 | 3.6 | 4.7 | 4.7 | 6.5 | 4.0 | 2.4 | 3.3 | 2.1 | 2.6 | 3.0 | 3.6 | 3.3 | 4.3 | 5.4 | 5.5 | 4.2 | 3.1 | 2.1 | 2.7 | 4.6 | 22.6 | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 4.1 | 3.3 | 3.7 | 4.3 | 70.6 | – | 10.5 | 4.6 | 4.1 | 4.8 | 19.7 | 23.8 | 4.8 | 2.2 | 0.6 | 0.3 | 1.0 | 0.3 | 0.4 | 1.3 | 1.9 | 2.5 | 27.6 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 5.6 | 6.6 | 6.0 | – | – | |
| -8.5% | -15.4% | -12.2% | -20.7% | -18.8% | -19.4% | -9.0% | -10.0% | -10.0% | -13.6% | -12.6% | -25.8% | -31.2% | -25.4% | -45.9% | -24.4% | -22.9% | -11.1% | -14.0% | -13.2% | -11.9% | -15.0% | -26.7% | -31.7% | -65.4% | -80.7% | -75.1% | -127.4% | -125.7% | -352.1% | -190.8% | -272.9% | -156.8% | -48.5% | -105.2% | -67.5% | -36.0% | -22.1% | -39.1% | -12.7% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -50.7% | -51.0% | -51.3% | -33.0% | -940.6% | -823.5% | -114.6% | -117.3% | -112.3% | -4.7% | -819.2% | -1,346.4% | -3.7% | 69.3% | 80.1% | 82.7% | 83.7% | 80.2% | 81.2% | 81.6% | 82.4% | 96.1% | 91.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -86.3% | -86.4% | -87.2% | -88.6% | -1,673.9% | -1,454.0% | -415.8% | -420.8% | -441.2% | -465.0% | -4,467.3% | -6,419.7% | -3,141.5% | -649.9% | -276.3% | -124.0% | -64.7% | -6.7% | 4.3% | 17.3% | 29.7% | -27.3% | -229.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -85.6% | -86.1% | -86.9% | -88.4% | -1,672.3% | -1,451.8% | -344.9% | -348.5% | -359.1% | -374.0% | -4,437.4% | -6,390.3% | -3,220.9% | -671.7% | -290.2% | -132.6% | -66.2% | -7.8% | 3.1% | 15.4% | 27.1% | -40.9% | -269.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -51.7% | -51.1% | -51.9% | -53.7% | -1,136.2% | -1,038.7% | -351.0% | -358.9% | -432.0% | -393.7% | -3,121.5% | -4,418.0% | -2,265.3% | -533.4% | -228.4% | -94.4% | -53.5% | -33.7% | -33.9% | -45.9% | -42.2% | -111.8% | -353.5% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -303.7% | -311.5% | -378.1% | -437.2% | -497.3% | -671.8% | -308.0% | -350.8% | -461.5% | -680.8% | -899.9% | -1,201.0% | -918.5% | -757.7% | -638.5% | -248.8% | -85.8% | -66.3% | -78.0% | -95.9% | -105.8% | -121.6% | -156.0% | -96.2% | -132.0% | -180.3% | -330.9% | -4,085.6% | – | – | – | – | – | – | – | – | – | – | – | – | |
| -288.5% | -299.5% | -364.6% | -396.0% | -445.9% | -548.7% | -285.9% | -322.2% | -419.9% | -588.8% | -786.9% | -1,017.6% | -801.8% | -642.5% | -538.9% | -221.5% | -74.9% | -52.1% | -58.8% | -69.6% | -72.9% | -72.7% | -88.1% | -56.8% | -67.1% | -60.7% | -71.2% | -123.6% | -153.7% | -166.8% | -141.0% | -154.4% | -93.3% | -78.3% | -25.2% | 15.7% | 77.6% | 161.5% | -47.3% | -79.4% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| -46 | -48 | -62 | -53 | -54 | -68 | -70 | -83 | -56 | -60 | -41 | – | – | -73 | – | – | – | -198 | -128 | -96 | -84 | -103 | – | -39 | -64 | -79 | -24 | -33 | -51 | -14 | -21 | -17 | -32 | -11 | 0.1 | -15 | 5.9 | 2.3 | -7.3 | -2.1 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1.0 | 0.2 | 0.1 | – | – | |
| 95.0% | 96.1% | 96.4% | 90.6% | 89.7% | 81.7% | 92.8% | 91.8% | 91.0% | 86.5% | 87.4% | 84.7% | 87.3% | 84.8% | 84.4% | 89.0% | 87.3% | 78.6% | 75.3% | 72.6% | 68.9% | 59.7% | 56.5% | 59.0% | 50.8% | 33.6% | 21.5% | 3.0% | -26.9% | -60.0% | -59.5% | -94.5% | -63.4% | -89.2% | -88.8% | -95.0% | -121.4% | -190.3% | -186.6% | -176.0% | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | – | – | 0.0 | – | – | – | 0.0 | 0.1 | 0.1 | 0.1 | 0.0 | – | 0.1 | 0.0 | 0.1 | 0.4 | 1.7 | – | – | – | – | – | – | – | – | – | – | – | – | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -712.32 | -683.46 | -758.38 | -826.50 | -840.17 | -974.61 | -854.13 | -894.20 | -1,024.09 | -1,259.91 | -1,384.92 | -1,502.16 | -1,331.45 | -955.26 | -659.32 | -348.81 | -93.56 | -89.86 | -85.14 | -86.21 | -87.63 | -87.30 | -86.85 | -60.78 | -60.31 | -55.32 | -51.69 | -72.44 | -68.20 | -63.84 | -41.45 | -29.47 | -17.84 | -7.99 | -1.44 | 0.47 | 1.73 | 2.57 | -0.67 | -1.11 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 104.98 | 98.88 | 99.19 | 99.09 | 5.22 | 5.98 | 17.62 | 17.31 | 15.40 | 13.82 | 1.63 | 1.07 | 1.98 | 6.17 | 10.16 | 13.45 | 12.06 | 18.41 | 15.33 | 11.20 | 9.50 | 1.64 | 0.41 | |
| 234.54 | 219.38 | 200.59 | 189.03 | 168.96 | 145.07 | 277.29 | 254.91 | 221.92 | 185.06 | 153.90 | 125.08 | 144.96 | 126.07 | 103.26 | 140.17 | 109.00 | 135.50 | 109.08 | 89.94 | 82.84 | 71.76 | 55.67 | 63.19 | 45.67 | 30.68 | 15.62 | 1.77 | -11.94 | -22.94 | -17.48 | -18.05 | -12.13 | -9.10 | -5.08 | -2.85 | -2.70 | -3.03 | -2.65 | -2.46 | |
| -45.61 | -54.51 | -62.73 | -72.49 | -78.15 | -87.87 | -87.84 | -91.58 | -103.92 | -117.80 | -125.78 | -129.51 | -109.95 | -104.64 | -97.51 | -89.05 | -74.51 | -54.30 | -50.51 | -51.47 | -53.17 | -59.31 | -62.13 | -61.87 | -62.11 | -66.54 | -54.42 | -50.96 | -47.15 | -44.90 | -32.92 | -23.20 | -12.70 | -6.45 | -6.21 | -5.20 | -5.15 | -4.01 | -1.84 | -1.46 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.